Literature DB >> 22411108

Cognitive behavior therapy after acquired brain injury: maintenance of therapeutic benefits at 6 months posttreatment.

April Arundine1, Cheryl L Bradbury, Kate Dupuis, Deirdre R Dawson, Lesley A Ruttan, Robin E A Green.   

Abstract

OBJECTIVES: To examine whether 6-month posttreatment acquired brain injury (ABI) patients receiving cognitive behavior therapy (CBT) adapted for ABI would demonstrate (1) maintenance of psychological benefits, (2) better community integration, and (3) commensurate benefits for both teletherapy and face-to-face group therapy. A secondary objective was to examine the relationship between coping strategies and mood and community integration. PARTICIPANTS: Seventeen chronic ABI patients with elevated psychological distress. OUTCOME MEASURES: Symptom Checklist-90-Revised (SCL-90-R), Depression Anxiety Stress Scales-21 (DASS-21), Community Integration Questionnaire, and the Ways of Coping questionnaire, revised. PROCEDURES: Eleven CBT sessions provided either in a face-to-face group format or individually by telephone with outcomes measured pretreatment, posttreatment, and at 6-month follow-up.
RESULTS: At 6-month follow-up, full-group scores were significantly better than pretreatment for psychological distress (t(16) = 6.22, P < .01, SCL-90-R; t(16) = 7.32, P < .01, DASS-21) and for community integration (t(16) = -6.15, P < .01), with negligible decrements from immediately posttreatment. Subgroup scores were comparable. Coping also improved but was uncorrelated with mood or community integration.
CONCLUSION: The CBT adapted for ABI shows enduring benefits for mood and community integration. The efficacy of teletherapy obviates service access problems related to geographical remoteness and mobility restrictions. A larger, randomized, control trial that examines underlying mechanisms of efficacy is needed.

Entities:  

Mesh:

Year:  2012        PMID: 22411108     DOI: 10.1097/HTR.0b013e3182125591

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  8 in total

Review 1.  Chronic traumatic encephalopathy: a critical appraisal.

Authors:  Benjamin Levin; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

2.  Factors associated with discharge destination from acute care after acquired brain injury in Ontario, Canada.

Authors:  Amy Y Chen; Brandon Zagorski; Daria Parsons; Rika Vander Laan; Vincy Chan; Angela Colantonio
Journal:  BMC Neurol       Date:  2012-03-24       Impact factor: 2.474

Review 3.  Mental distress in patients with cerebral visual injury assessed with the german brief symptom inventory.

Authors:  Carolin Gall; Doreen Brösel; Gabriele Helga Franke
Journal:  Front Aging Neurosci       Date:  2015-05-04       Impact factor: 5.750

4.  Treating anxiety after stroke using cognitive-behaviour therapy: two cases.

Authors:  Ian I Kneebone; Fiona W Jeffries
Journal:  Neuropsychol Rehabil       Date:  2013-07-26       Impact factor: 2.868

Review 5.  Negative neuroplasticity in chronic traumatic brain injury and implications for neurorehabilitation.

Authors:  Jennifer C Tomaszczyk; Nathaniel L Green; Diana Frasca; Brenda Colella; Gary R Turner; Bruce K Christensen; Robin E A Green
Journal:  Neuropsychol Rev       Date:  2014-11-25       Impact factor: 7.444

Review 6.  A narrative literature review of depression following traumatic brain injury: prevalence, impact, and management challenges.

Authors:  Shannon B Juengst; Raj G Kumar; Amy K Wagner
Journal:  Psychol Res Behav Manag       Date:  2017-06-14

Review 7.  Psychological Intervention in Traumatic Brain Injury Patients.

Authors:  Lizzette Gómez-de-Regil; Damaris F Estrella-Castillo; Julio Vega-Cauich
Journal:  Behav Neurol       Date:  2019-05-02       Impact factor: 3.342

8.  Defining Acute Traumatic Encephalopathy: Methods of the "HEAD Injury Serum Markers and Multi-Modalities for Assessing Response to Trauma" (HeadSMART II) Study.

Authors:  W Frank Peacock; Damon Kuehl; Jeff Bazarian; Adam J Singer; Chad Cannon; Zubaid Rafique; James P d'Etienne; Robert Welch; Carol Clark; Ramon Diaz-Arrastia
Journal:  Front Neurol       Date:  2021-12-08       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.